Kane Biotech Announces Grant of Options and Updates Investor Relations Agreement – msnbc.com

Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, announces that the Company has granted an aggregate of 1,032,500 stock options at an …